Skip to content

Nasdaq · CIK 0001479615

SLN Silence Therapeutics plc

Insider trading from SEC Form 4. Last filing Jun 30, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company

Signals

Open-market buys and sells at Silence Therapeutics plc, scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The last 54 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 26, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+65,739--11,580,173Jun 30, 2025
Jun 26, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+20,735--11,600,908Jun 30, 2025
Jun 27, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+24,000--11,624,908Jun 30, 2025
Jun 22, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+20,977--11,452,805Jun 25, 2025
Jun 23, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+35,005--11,487,810Jun 25, 2025
Jun 24, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+26,624--11,514,434Jun 25, 2025
Jun 17, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+31,399--11,392,779Jun 20, 2025
Jun 18, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+39,049--11,431,828Jun 20, 2025
Jun 12, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+39,305--11,361,380Jun 13, 2025
May 26, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+26,669--11,262,906May 29, 2025
May 27, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+50,000--11,312,906May 29, 2025
May 28, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+9,169--11,322,075May 29, 2025
May 22, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+19,174--11,219,050May 27, 2025
May 23, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+17,187--11,236,237May 27, 2025
May 18, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+37,023--11,157,876May 21, 2025
May 19, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+26,000--11,183,876May 21, 2025
May 20, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+16,000--11,199,876May 21, 2025
May 5, 2025Timothy McInerney
director
AGrant or award
Share Option (Right to Buy)derivative
+48,000$0.00$048,000May 20, 2025
May 13, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+94,234--11,065,087May 15, 2025
May 14, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+55,766--11,120,853May 15, 2025
May 5, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+100,000--10,820,853May 8, 2025
May 6, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+100,000--10,920,850May 8, 2025
May 7, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+50,000--10,970,853May 8, 2025
Apr 30, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+34,309--10,645,587May 2, 2025
May 1, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+75,266--10,720,853May 2, 2025
Apr 28, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+95,211--10,556,510Apr 30, 2025
Apr 29, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+54,768--10,611,278Apr 30, 2025
Apr 24, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+90,432--10,401,731Apr 28, 2025
Apr 25, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+59,568--10,461,299Apr 28, 2025
Apr 22, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+50,000--10,261,299Apr 24, 2025
Apr 23, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+50,000--10,311,299Apr 24, 2025
Apr 17, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+50,000--10,111,299Apr 22, 2025
Apr 21, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+100,000--10,211,299Apr 22, 2025
Apr 10, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+25,193--9,886,492Apr 15, 2025
Apr 11, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+56,480--9,942,972Apr 15, 2025
Apr 14, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+40,409--9,983,381Apr 15, 2025
Apr 14, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+50,000--10,033,381Apr 15, 2025
Apr 15, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+27,918--10,061,299Apr 15, 2025
Mar 31, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+100,000--9,861,299Apr 1, 2025
Mar 27, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+50,000--9,611,299Mar 31, 2025
Mar 28, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+50,000--9,661,299Mar 31, 2025
Mar 31, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+100,000--9,761,299Mar 31, 2025
Mar 5, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+22,632--9,561,299Mar 6, 2025
Jan 8, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+30,000--9,118,667Feb 25, 2025
Jan 17, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+150,000--9,268,667Feb 25, 2025
Jan 21, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+25,000--9,293,667Feb 25, 2025
Jan 21, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+20,000--9,313,667Feb 25, 2025
Jan 23, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+12,226--9,325,893Feb 25, 2025
Feb 13, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivativeindirect: By Cream Capital Limited
+92,774--9,418,667Feb 25, 2025
Feb 13, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+60,000--9,478,667Feb 25, 2025
Feb 18, 2025Richard Ian Griffiths
owner
POpen-market purchase
American Depositary Sharesderivative
+60,000--9,538,667Feb 25, 2025
Jan 2, 2025Michael H. Davidson
director
AGrant or award
Share Option (Right to Buy)derivative
+48,000$0.00$048,000Jan 6, 2025
Jan 2, 2025James Ede-Golightly
director
AGrant or award
Share Option (Right to Buy)derivative
+48,000$0.00$048,000Jan 6, 2025
Jan 2, 2025Rhonda Lynette Hellums
Chief Financial Officer
AGrant or award
Employee Share Option (Right to Buy)derivative
+375,000$0.00$0375,000Jan 6, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

SLN insider trading: Silence Therapeutics plc | InsiderTell